Section He-P 4035.74 - Training for an Authorized Nuclear Pharmacist Except as provided He-P 4035.71, the licensee shall require the authorized nuclear pharmacist to be a licensed pharmacist, as defined in RSA 318:1, VII, who:
(a) Is certified by a specialty board whose certification process has been recognized by DHHS/RHS, or an agreement state, or the Nuclear Regulatory Commission. The names of board certifications that have been recognized by DHHS/RHS, an agreement state, or the Nuclear Regulatory Commission are posted on the NRC's medical use licensee toolkit web page. To have its certification process recognized, a specialty board shall require all candidates for certification to:(1) Have graduated from a pharmacy program accredited by the American Council on Pharmaceutical Education (ACPE) or have passed the Foreign Pharmacy Graduate Examination Committee (FPGEC) examination;(2) Hold a current, active license to practice pharmacy;(3) Provide evidence of having acquired at least 4000 hours of training/experience in nuclear pharmacy practice. Academic training may be substituted for no more than 2000 hours of the required training and experience; and(4) Pass an examination in nuclear pharmacy administered by diplomats of the specialty board, that assesses knowledge and competency in procurement, compounding, quality assurance, dispensing, distribution, health and safety, radiation safety, provision of information and consultation, monitoring patient outcomes, research and development; or(b) Has met the following requirements: (1) Have completed 700 hours in a structured educational program consisting of both: a. 200 hours of classroom and laboratory training in the following areas: 1. Radiation physics and instrumentation;3. Mathematics pertaining to the use and measurement of radioactivity;4. Chemistry of byproduct material for medical use; and5. Radiation biology; andb. Supervised practical experience in a nuclear pharmacy involving the following: 1. Shipping, receiving, and performing related radiation surveys;2. Using and performing checks for proper operation of instruments used to determine the activity of dosages, survey meters, and, if appropriate, instruments used to measure alpha- or beta-emitting radionuclides; 3 Calculating, assaying, and safely preparing dosages for patients or human research subjects;4 Using administrative controls to avoid medical events in the administration of byproduct material;5. Using procedures to prevent or minimize radioactive contamination and using proper decontamination procedures; and(2) Has obtained a written attestation, signed by a preceptor authorized nuclear pharmacist, that the individual has satisfactorily completed the requirements in He-P 4035.74(b)(1) and is able to independently operate as an authorized nuclear pharmacist.N.H. Admin. Code § He-P 4035.74
(See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07
New. #8959, eff 8-7-07
Amended by Volume XXXV, Number 32 Filed August 13, 2015, Proposed by #10897, Effective 7/22/2015, Expires1/18/2016.Amended by Volume XXXVI Number 01, Filed January 7, 2016, Proposed by #11011, Effective 1/15/2016, Expires 1/15/2026.Amended by Volume XL Number 24, Filed June 11, 2020, Proposed by #13048, Effective 6/2/2020, Expires 6/2/2030.